Demand for lung cancer diagnostics will cultivate at a CAGR of around 7% and prospective to record market value at US$ 4 Bn By 2021-2031; States Fact.MR

Increasing R&D Activities And Product Approvals Are Expected To Drive Growth Of The Global Lung Cancer Diagnostic And Screening Market.

“Rapid technological advancements with respect to human diagnostics is prompting lung cancer diagnostics service providers to leverage key advancements, including AI and automation, opening lucrative growth frontiers,” comments a Fact.MR analyst.

Fact.MR – a market research and competitive intelligence provider, The global market for lung cancer diagnostics market is projected to reach US$ 4 Bn, experiencing a growth rate of over 7% CAGR during the forecast period 2021-2031. The market for lung cancer diagnostics was estimated at US$ 1.6 Bn in 2016 with an expansion rate of approximately 6% until 2020. Growing number of private diagnostic laboratories spurred demand in the historical period.

Increasing spending on cancer treatment research is offering lucrative opportunities for the growth of the early-stage lung cancer diagnostics market. Majority of lung cancer patients are diagnosed at advanced stages which cannot be cured by surgery or other therapeutic modalities.

Historically, the market expanded at nearly 6% CAGR, closing in at around US$ 2 Bn by 2020. Despite the onset of COVID-19, the landscape experienced high growth, as healthcare provider’s prioritized respiratory health above everything else.

For more insights into the Market, Get A Sample of this Report!

Liquid biopsy and breath analysis developments are the most promising and advanced technologies for the detection of biomarkers associated with lung cancer.

Manufacturers are emphasizing on wearable devices and AI- two niche areas requiring development and standardization for commercialization. The upcoming technology based on nanosystems includes robots, fibres, and particles for sensitive detection of lung cancer are expected to add traction to the lung cancer diagnostics market.

Key Takeaways from Market Study

  • By test type, CA lung cancer diagnostic tests to reign supreme, clocking US$ 1 Bn by 2031
  • Hospital-associated labs set to reach around US$ 1.6 Bn until 2031
  • Treatment for non-small cell lung cancer (NSCLC) to comprise over 50% of total demand
  • Cancer research institutes to make significant use of lung cancer diagnostics, expanding at 6% CAGR
  • Angiogenesis inhibitors is the fastest growing segment followed by HER2 tests
  • U.S to acquire around 27% market share in the global lung cancer diagnostics industry
  • China is expected to register a CAGR of around 8% until 2031, with NSCLC treatment gaining traction

For Comprehensive Insights Ask An Analyst Here

Competitive Landscape

Prominent players are embracing innovative approaches such as ground-breaking marketing tactics, technological advances for cancer screening, mergers, and acquisitions.

  • In March 2021, Next-generation sequencing (NGS)-based precision oncology provider Geneseeq Technology Inc. collaborated with Illumina, Inc. (to develop comprehensive in-vitro diagnostic (IVD) NGS testing kits for cancer, using Illumina's NextSeq™ 550Dx sequencing platform.
  • In Jan 2017, Abbott Laboratories completed largest the acquisition of St.Jude Medical for US$ 25 Bn. Together, the company will compete in nearly every area of the $30 billion cardiovascular markets and hold the No. 1 or 2 positions across large and high-growth cardiovascular device markets.

Segmentation Covered In this Report:

  • By Test Type:
    • CA Test for Lung Cancer Diagnostics
    • HER2 Tests for Lung Cancer Diagnostics
    • ALK Tests for Lung Cancer Diagnostics
    • Angiogenesis Inhibitor for Lung Cancer Diagnostics
    • EGFR Mutation Tests for Lung Cancer Diagnostics
    • KRAS Mutation Tests for Lung Cancer Diagnostics
    • Others
  • By End-User:
    • Lung Cancer Diagnostics for Hospital Associated Labs
    • Lung Cancer Diagnostics for Independent Diagnostic Laboratories
    • Lung Cancer Diagnostics for Cancer Research Institutes
    • Others
  • By Indication:
    • Non-Small-cell Lung Cancer Diagnostics
    • Small-cell Lung Cancer Diagnostics

Get Customization on this Report for Specific Research Solutions

More Insights Available

Fact.MR, in its new offering, presents an unbiased analysis of the lung cancer diagnostics market, presenting historical demand data (2016-2020) and forecast statistics from 2021 to 2031.

The study divulges essential insights on the market based on the test type (CA Test, HER2 Tests, ALK Tests, Angiogenesis Inhibitor, EGFR mutation tests and KRAS mutation tests) end-user (hospital associated labs, independent diagnostic laboratories, cancer research institutes) and indication (non-small-cell lung cancer, small-cell lung cancer) across seven regions (North America, Latin America, Europe, South Asia, East Asia, Oceania and MEA)

Check out more studies related to Healthcare Industry, conducted by Fact.MR:

Sepsis Diagnostics Market - Sepsis Diagnostics Market Analysis by Product (Blood Culture Media, Instruments and Assays & Reagents), Method (Conventional Sepsis Diagnostics, Automated Sepsis Diagnostics, Pathogen, Gram-negative Bacterial Sepsis, Gram-positive Bacterial Sepsis, Fungal Sepsis and Other Pathogens), Technology (Microbiology, Molecular Diagnostics, Immunoassays and Other Technologies) and Region Forecast- 2022-2032

NGS Sample Preparation Market - NGS Sample Preparation Market Analysis by Product Type (NGS Sample Preparation Instruments and NGS Sample Preparation Kits and Reagents & Consumables), Application (NGS Sample Preparation for Drug & Biomarker Discovery, NGS Sample Preparation for Diagnostics, NGS Sample Preparation for Precision Medicines and Others (Agriculture and Animal Research)), End User (Hospitals & Diagnostic Centers, Biotechnology & Pharmaceutical Companies, Academic & Research Institutes and Others (CROs and CMOs) and Region Forecast- 2022-2032

Osteoporosis Therapeutics Market - Osteoporosis Therapeutics Market Analysis, By Drug Class (Bisphosphonates, Selective Estrogen Inhibitor Modulators (SERM), Parathyroid Hormone Therapies, Calcitonin, Rank Ligand Inhibitors), By Route of Administration (Oral, Injectables) - Global Market Insights 2022 to 2026

CNS Therapeutics Market - CNS Therapeutics Market Analysis, By Segment (Pain Management, Anti-psychotics, Anti-depressants, Anti-epilepsy, Anti-Alzheimer’s, Anti-Parkinson’s) - Global Market Insights 2022 to 2026

Newborn Screening Market - Newborn Screening Market by Product (Newborn Screening Instruments, Consumables), by Test Type (Dry Blood Spot Tests, Hearing Tests, Critical Congenital Heart Disease (CCHD) Screening Tests), by Technology (Immunoassays & Enzymatic Screening Tests, Tandem Mass Spectrometry, Molecular Assays, Hearing Screening Technologies, Pulse Oximetry, Others), by End User (Clinical Laboratories, Hospitals) and by Region- 2022 to 2032

Doxorubicin Market - Doxorubicin Market Analysis, By Formulation (Lyophilized Doxorubicin Powder, Doxorubicin Solution), By Cancer Type (Breast Cancer, Prostate Cancer, Ovarian Cancer, Lung Cancer, Bladder Cancer, Stomach Cancer, Leukemia), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, e-Commerce) - Global Market Insights 2022 to 2026

Drug Discovery Services Market - Drug Discovery Services Market Analysis by Process (Target Selection, Target Validation, Hit-To-Lead Identification, Lead Optimization and Candidate Validation), by Type (Medicinal Chemistry, Biology Services, Drug Metabolism and Pharmacokinetics), by Drug Type (Small Molecules and Biologics) by Therapeutic Area (Oncology, Neurology, Cardiovascular Diseases, Respiratory Diseases, Diabetes and Other Therapeutic Areas) and Region Forecast- 2022-2032

Lab Automation Market - Lab Automation Market by Product (Equipment, Microplate Readers, Software & Informatics, Automated ELISA Systems, Automated Nucleic Acid Purification Systems), by Application (Drug Discovery, Clinical Diagnostics, Genomics Solutions, Proteomics Solutions), by End User (Biotechnology & Pharmaceutical Industries, Research & Academic Institutes, Hospitals & Diagnostic Centers, Forensic Laboratories, Environmental Testing Labs, Food & Beverage Industry) & Region - Forecast to 2021-2031

Animal Model Market - Animal Model Market Analysis by Species (Rats, Mice, Guinea Pig, Rabbits, Monkeys, Dogs, Pigs, Cats, and Other Species), by Application (Basic & Applied Research and Drug Discovery/Development), by End User (Academic & Research Institutions, Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations (CROs), and Other End Users) and Region Forecast- 2022-2032

Contrast Media Injectors Market - Contrast Media Injectors Market by Product (Consumables, Injector Systems, Accessories), Application (Radiology, Interventional Radiology, Interventional Cardiology), End-User (Hospitals, Diagnostic Imaging Centers), & Regional Analysis till 2032

Epigenetics Market - Epigenetics Market Analysis, By Product (Kits, Reagents, Enzymes, Bioinformatics Tools, Instruments & Consumables) By Application (Immunology, Oncology, Cardiovascular Diseases, Metabolic Diseases, Non-Oncology) By Technology (DNA Methylation, Histone Methylation, Histone Acetylation, MicroRNA Modification, Chromatic Structures) - Global Market Insights 2022 to 2032

Fact.MR’s Domain Knowledge in Healthcare

Our healthcare consulting team guides organizations at each step of their business strategy by helping you understand how the latest influencers account for operational and strategic transformation in the healthcare sector. Our expertise in recognizing the challenges and trends impacting the global healthcare industry provides indispensable insights and support - encasing a strategic perspective that helps you identify critical issues and devise appropriate solutions.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.


Mahendra Singh

US Sales Office:

11140 Rockville Pike

Suite 400

Rockville, MD 20852


Tel: +1 (628) 251-158

Back to news